PRLD Analyst Estimates: Price Targets, Revenue, Net Income, and EBIT Forecast - Prelude Therapeutics Inc - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 3.77 USD -1.82%

Updated:

Section:

Wall Street
Price Targets

Wall Street analysts forecast PRLD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PRLD is 5.92 USD with a low forecast of 3.03 USD and a high forecast of 10.5 USD.

PRLD Lowest Forecast

Wall Street Target

PRLD Average Forecast

Wall Street Target

PRLD Highest Forecast

Wall Street Target

20% Downside

57% Upside

179% Upside

The latest public price target was made on Mar 13, 2024 by Reni Benjamin from JMP Securities , who expects PRLD stock to rise by 86% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst	Price Target	Date	Article
Reni Benjamin JMP Securities	7 USD Upside 86%	1 month ago Mar 13, 2024	JMP Securities Starts Prelude Therapeutics (PRLD) at Market Outperform, 'Precision Targeting of SMARCA Drives Cell Kill' StreetInsider

Price Target	7 USD
Upside/Downside	86%

Enlivex Therapeutics Ltd

328% Upside

Eliem Therapeutics Inc

37% Downside

Poseida Therapeutics Inc

490% Upside

EuBiologics Co Ltd

14% Upside

Enlivex Therapeutics Ltd

328% Upside

Eliem Therapeutics Inc

37% Downside

Poseida Therapeutics Inc

490% Upside

EuBiologics Co Ltd

14% Upside

CSL Ltd

11% Upside

Takara Bio Inc

100% Upside

SAB Biotherapeutics Inc

328% Upside

Harpoon Therapeutics Inc

8% Upside

Revenue
Forecast

N/A

N/A

N/A

N/A

What are analyst estimates?

Operating Income
Forecast

N/A

N/A

-1%

What are analyst estimates?

Net Income
Forecast

N/A

N/A

-17%

What are analyst estimates?

See Also

Relative Valuation

Wall Street Estimates

Profitability Analysis

Solvency Analysis

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

According to Wall Street analysts, the average 1-year price target for PRLD is 5.92 USD with a low forecast of 3.03 USD and a high forecast of 10.5 USD.

Join more than 133,100+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.